Companies: 10,795·Total market cap: $144.5T
Molecule Holdings Inc.

Molecule Holdings Inc.

EVRRFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$626130
P/E Ratio
52W High$0.0025
52W Low$0.0025

Molecule Holdings Inc. (EVRRF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

evrrf · pe ratio · data through Oct 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Molecule Holdings Inc. (EVRRF) measures how much investors pay for each dollar of the company's trailing earnings. EVRRF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.05.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-10-31

Forward P/E
N/A
EPS (TTM)
-$0.05
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Molecule Holdings Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Molecule Holdings Inc.
Molecule Holdings Inc.You
EVRRF
$1MN/A-$0.05
Avicanna Inc.
Avicanna Inc.
AVCNF
$10MN/A-$0.02
INDVR Brands Inc.
INDVR Brands Inc.
CAAOF
$0MN/A-$0.06
Choom Holdings Inc.
Choom Holdings Inc.
CHOOF
$0MN/A-$0.07
CareView Communications, Inc.
CareView Communications, Inc.
CRVW
$32MN/A-$0.01
Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc.
CWBHF
$67MN/A-$0.19
Global Pharmatech, Inc.
Global Pharmatech, Inc.
GBLP
$29MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-10-31Latest
FY2022
$-0.05
2021-10-31
FY2021
$-0.05
2020-10-31
FY2020
$-0.04
2019-10-31
FY2019
$-0.23

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Molecule Holdings Inc. (EVRRF) measures how much investors pay for each dollar of the company's trailing earnings. EVRRF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.05.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.05 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EVRRF pe ratio · 6 questions

EVRRF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via EVRRF's SEC 10-K and 10-Q filings.

EVRRF PE ratioWhat is EVRRF PE ratioCurrent PE ratio of EVRRFEVRRF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Molecule Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09